文献速递创伤骨科骨质疏松与代谢性骨病关节外科

2010至2020年假体周围骨折后骨质疏松筛查与治疗的趋势

Trends in screening and treatment of osteoporosis after periprosthetic fractures from 2010 to 2020.
PubMed 文献 · Osteoporos Int · 2025-01-15

本研究利用大型国家行政数据库,纳入2010至2020年间发生下肢假体周围骨折且无既往骨质疏松筛查或治疗史的40岁以上患者,评估骨折后1年内双能X线吸收测定法(DXA)筛查和抗骨质疏松药物治疗率的变化趋势。结果显示,骨质疏松筛查率为5.7%、治疗率为3.6%,2010至2020年间筛查、治疗或任一干预率均无显著变化。

要点

  • 假体周围骨折后1年内骨质疏松筛查率为5.7%,治疗率为3.6%。
  • 2010至2020年间骨质疏松筛查率无显著变化(复合年增长率+0.1%,p=0.13)。
  • 治疗率(复合年增长率-2.4%,p=0.29)和任一干预率(复合年增长率-1.1%,p=0.77)亦无显著变化。

核心结论

  • 2010至2020年间,假体周围骨折后1年内骨质疏松筛查或治疗率无显著变化。
  • 骨科医生和相关医疗工作者可在遏制骨质疏松流行中发挥重要作用。

研究设计与样本

  • 利用大型国家行政数据库识别2010至2020年间发生下肢假体周围骨折、年龄大于40岁且无既往骨质疏松筛查或治疗史的患者。
  • 确定骨折后1年内采用双能X线吸收测定法(DXA)测量骨密度和使用药物治疗骨质疏松或任一干预的发生率。
  • 使用复合年增长率(CAGR)计算干预率变化,并用线性回归判断趋势是否具有统计学意义。

主要发现

  • 总人群中,5.7%的患者接受了骨质疏松筛查,3.6%接受了治疗。
  • 2010至2020年间,骨质疏松筛查率无显著变化(CAGR +0.1%;p=0.13)。
  • 2010至2020年间,骨质疏松治疗率无显著变化(CAGR -2.4%;p=0.29)。
  • 2010至2020年间,任一干预率无显著变化(CAGR -1.1%;p=0.77)。
  • 与干预相关的因素包括年龄较大、女性性别和合并症增多。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Osteoporosis is often underrecognized and undertreated following periprosthetic fractures (PPF). Our study found that between 2010 and 2020, there has been no significant change in the rates of osteoporosis screening or treatment within 1 year following PPF. Orthopedic surgeons can play an integral role in helping to curtail the osteoporosis epidemic. PURPOSE: Periprosthetic fractures (PPF) typically occur from low-energy mechanisms and are pathognomonic for osteoporosis. However, osteoporosis is often underrecognized and undertreated. The aim of this study was to examine trends in dual energy X-ray absorptiometry (DXA) scans and treatment of osteoporosis after PPF between 2010 and 2020. METHODS: Patients older than 40 who experienced a lower extremity PPF between 2010 and 2020 and had no prior history of osteoporosis screening or treatment were identified utilizing a large national administrative database. Rates of bone mineral density (BMD) measurement using DXA and anti-osteoporotic treatment with pharmacotherapy, or either intervention within 1 year following experiencing a PPF were determined. The rate of change for these interventions was calculated using the compounded annual growth rate (CAGR), with linear regression used to determine whether trends were statistically significant. RESULTS: In total, 5.7% and 3.6% of patients were screened and treated for osteoporosis, respectively. Between 2010 and 2020, there was no significant change in rates of osteoporosis screening (CAGR + 0.1%; p = 0.13), treatment (CAGR - 2.4%; p = 0.29), or either intervention (CAGR - 1.1%; p = 0.77) within 1 year following PPF. Factors associated with intervention included older age, female sex, and increased comorbidities. CONCLUSION: Our study found that there has been no significant change in the rates of osteoporosis screening or treatment within 1 year following PPF. Orthopedic surgeons and allied healthcare workers can play an integral role in helping to curtail the osteoporosis epidemic.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Durbin JW, Zhao AY, Cui E, et al. Trends in screening and treatment of osteoporosis after periprosthetic fractures from 2010 to 2020. Osteoporos Int. 2025. PMID: 39812673. doi:10.1007/s00198-025-07385-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。